Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$220.22
Based on 6.5% avg growth
INTRINSIC VALUE TODAY
$136.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.0x Exit PE.
Valuation Analysis: MMM is currently trading at $160.44, which is considered slightly high relative to its 30-day fair value range of $153.50 to $162.64. The stock's valuation (Forward PE: 16.9) is in line with its historical norms (17.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, MMM is in a strong uptrend. The price is currently testing key support at $159.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$153.50 -
$162.64
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
60.5%
All Signals
NEUTRAL: Mixed technical signals (55/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($171.02)
Trading Range Analysis
30-Day Trading Range
$153.50 -
$162.64
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level$159.22
Resistance Level$169.76
Current TrendStrong Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)16.92
Wall Street Target
$171.02
(+6.6%)
Revenue Growth (YoY)1.3%
Earnings Growth (YoY)-39.7%
Profit Margin11.1%
Valuation Discount vs History
-0.2% cheaper
PE vs Historical
16.9 vs 17.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):-0.2%
(market-implied from PE analysis)
1-Year Target
$160.12
(0%)
2-Year Target
$159.80
(0%)
3-Year Target
$159.48
(-1%)
3-Yr Target (if PE normalizes)
(PE: 17→17)
$160.25
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.9%)
$266.50
(+66%)
Base:
(SPY PE: 16.9, Growth: 8.9%)
$207.01
(+29%)
Bear:
(PE: 14.4, Growth: 8.9%)
$175.96
(+10%)
📈Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 30.88 | Current EPS (TTM): $5.18
Bull Case
$322.13
(+101%)
Analyst growth 83.1%, PE expands to 34.0
Base Case
$292.85
(+83%)
Market implied 83.1%, PE stable at 30.9
Bear Case
$108.77
(-32%)
Severe decline -20.0%, PE contracts to 26.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.9 to 17.0
Stabilization Target:
$161.22
(+0.5%)
PE Expansion Potential:
+0.5%
Share & Embed Analysis
Found this analysis useful? Share it with your community or embed the live chart on your blog.
3M, a multinational conglomerate founded in 1902, sells tens of thousands of products ranging from sponges to respirators. The firm is well known for its extensive research and development capabilities, and it is a pioneer in inventing new use cases for its proprietary technologies. 3M is organized across three business segments: safety and industrial (representing around 44% of revenue), transportation and electronics (36%), and consumer (20%). The firm recently spun off its healthcare business, now known as Solventum. Nearly half of 3M's revenue comes from outside the Americas.